PSMC2 Monoclonal Antibody
Applications
Reactivity
Predicted Reactivity
| Overview | |
| Catalog # | bsm-51697m |
| Product Name | PSMC2 Monoclonal Antibody |
| Applications |
WB
|
| Reactivity | Human |
| Predicted Reactivity | Mouse, Cow |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Mouse |
| Source | Recombinant human PSMC2. |
| Clonality | Monoclonal |
| Clone # | G5K1 |
| Concentration | 0.5ug/ul |
| Storage Buffer | 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| Target | |
| Gene ID | 5701 |
| Swiss Prot | P35998 |
| Subcellular location | Cytoplasm, Nucleus |
| Synonyms | 26S protease regulatory subunit 7; PRS7_HUMAN; 26S protease complex; 26S proteasome AAA-ATPase subunit RPT1; mammalian suppressor of sgv-1 of yeast; MSS1; Nbla10058; protease 26S subunit 7; proteasome 26S ATPase subunit 2; Proteasome 26S subunit ATPase 2; proteasome 26S subunit ATPase 2; Protein MSS1; putative protein product of Nbla10058; S7 antibody. |
| Background | The 26S protease is involved in the ATP-dependent degradation of ubiquitinated proteins. The regulatory (or ATPase) complex confers ATP dependency and substrate specificity to the 26S complex. In case of HIV-1 infection, positive modulator of Tat-mediated transactivation. |
| Application Dilution | |
| WB | =1:500-2000 |